Conn. sues FDA for OxyContin warnings

If your petition doesn't succeed, go to court. That's what Connecticut Attorney General Richard Blumenthal has done: He's sued the FDA to force the agency to act on his bid for tougher warnings on the painkiller OxyContin, so-called "hillbilly heroin" that is widely abused. At issue, Blumenthal says, is that drug labeling recommends dosing every 12 hours, but 20 percent of all OxyContin scrips were written for dosing every eight hours or less. Drugmaker Purdue Pharma's internal documents show that many docs have been prescribing the drug inappropriately, the AG alleges.

Blumenthal's 2004 petition asked the agency to require Purdue Pharma to strengthen the med's black-box warning and issue a "Dear Healthcare Professional" letter about the shorter-term dosing risks. "The FDA has irresponsibly and illegally ignored the clear need for warnings about OxyContin prescription practices," the AG alleges. "Prescription narcotic abuse of drugs like OxyContin has become the biggest drug threat in the Northeast."

- read the AG's press release
- see the Pharmalot item
- check out the article at Legal Newsline

ALSO: OxyContin abuse in the Seattle area has soared, with the med quickly replacing crystal meth as the recreational drug of choice. Addicts have even been breaking into nursing homes and robbing people's personal medicine chests. Report

Related Articles:
Purdue execs plead guilty to OxyContin fraud. Report
Kentucky sues Purdue over drug abuse. Report
Oxycontin users sue Purdue. Report

Suggested Articles

Imbruvica has enjoyed a nice run in previously untreated CLL over the last few years. But major competition is here in the form of AZ's Calquence.

Pennsylvania's Supreme Court revived thousands of lawsuits alleging the antipsychotic med Risperdal caused males to develop breasts.

In the asthma biologics race, there doesn't appear to be a clear favorite among Xolair, Dupixent, Fasenra and Nucala for a group of pulmonologists.